CN113144076A - Traditional Chinese medicine composition for treating myocarditis - Google Patents

Traditional Chinese medicine composition for treating myocarditis Download PDF

Info

Publication number
CN113144076A
CN113144076A CN202110561632.5A CN202110561632A CN113144076A CN 113144076 A CN113144076 A CN 113144076A CN 202110561632 A CN202110561632 A CN 202110561632A CN 113144076 A CN113144076 A CN 113144076A
Authority
CN
China
Prior art keywords
parts
traditional chinese
chinese medicine
myocarditis
medicine composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN202110561632.5A
Other languages
Chinese (zh)
Inventor
仲崇允
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CN113144076A publication Critical patent/CN113144076A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/21Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/24Apocynaceae (Dogbane family), e.g. plumeria or periwinkle
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/84Valerianaceae (Valerian family), e.g. valerian
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a traditional Chinese medicine composition for treating myocarditis, which is prepared from the following raw materials in parts by weight: 3-9 parts of evergreen; 6-12 parts of dogbane leaves; 9-18 parts of achyranthes aspera and abelmoschus manihot; 15-30 parts of mistletoe. The invention has the characteristics of obvious treatment effect, short treatment period, no toxic or side effect and the like.

Description

Traditional Chinese medicine composition for treating myocarditis
Technical Field
The invention belongs to the technical field of traditional Chinese medicines, and particularly relates to a traditional Chinese medicine composition for treating myocarditis.
Background
Myocarditis refers to a disease mainly manifested by localized or diffuse inflammatory lesions of the myocardium and is classified into fulminant myocarditis, acute myocarditis, chronic active myocarditis, and chronic persistent myocarditis. Myocarditis has a wide variety of clinical manifestations ranging from asymptomatic to severe arrhythmias, acute cardiac insufficiency, cardiogenic shock and even death. No special medicine is available at present for treating myocarditis, and the treatment of myocarditis mainly comprises symptomatic auxiliary support treatment and mainly comprises active treatment of shock, heart failure, arrhythmia and other comprehensive treatments.
Disclosure of Invention
The invention aims to improve the defects of the prior art and provides the traditional Chinese medicine composition for treating myocarditis, which has the characteristics of obvious treatment effect, short treatment period, no toxic or side effect and the like.
Traditional Chinese medicine considers that myocarditis belongs to the categories of palpitation (including ancient severe palpitation) and cardiodynia. Deficiency is the root of the disease, toxicity is the important condition of the disease, and dampness, stasis and phlegm are different pathological changes in the course of the disease. Myocarditis is caused by the invasion of pathogenic wind-heat or damp-heat by the body's deficiency of healthy qi and the invasion of pathogenic factors into the heart.
Based on the theory, the technical scheme of the invention is as follows: an oral administration traditional Chinese medicine for treating myocarditis is composed of the following raw material medicines in parts by weight: 3-9 parts of evergreen; 6-12 parts of dogbane leaves; 9-18 parts of achyranthes aspera and abelmoschus manihot; 15-30 parts of mistletoe.
In a preferred embodiment, the traditional Chinese medicine composition for treating myocarditis is prepared from the following raw material medicines in parts by weight: 9 parts of evergreen; 12 parts of dogbane leaves; 18 parts of achyranthes aspera and abelmoschus manihot; 15-30 parts of mistletoe.
Wherein, the yellow hollyhock flower: sweet and cold in nature. Clear heat and remove toxicity, moisten dryness and smooth intestines. Abelmoschus manihot can inhibit myocardial lipid peroxidation and myocardial inflammatory reaction and protect myocardial cells.
And (3) dogbane leaf: sweet, bitter and cool. It enters liver meridian. Pacify liver, tranquilize mind, clear heat and induce diuresis. Folium Apocyni Veneti can increase cardiac glycogen resynthesis, treat cardiovascular function deficiency, relieve acute circulatory disturbance symptom of myocarditis, and prevent myocardial and coronary arteriosclerosis.
Mistletoe: sweet; bitter; the nature is mild. Dispelling wind-damp; strengthening bones and muscles; nourishing liver and kidney; promoting blood circulation to arrest pain; preventing miscarriage; and (4) feeding milk. Treating arrhythmia caused by myocarditis sequela, and promoting specific and nonspecific immunity.
Achyranthes aspera: sweet in taste; slightly bitter; micro-acid; is cold in nature. Liver diseases entering; the kidney channel. Promoting blood circulation and removing blood stasis; purging pathogenic fire and removing toxic substances; induce diuresis to treat stranguria. Treating viral myocarditis.
Evergreen: bitter, sweet and cold in taste. Has little toxicity. Entering the lung; the heart meridian. Clearing away heat and toxic materials, tonifying heart, and promoting urination; cool blood and stop bleeding. Treating viral myocarditis.
The invention is prepared from Chinese traditional herbal medicines, and the traditional Chinese medicine composition for treating myocarditis is combined by orderly matching certain natural extracts with definite components and clear effects according to a plurality of principles of traditional Chinese medicine treatment based on syndrome differentiation and modern medicine.
The traditional Chinese medicine composition has the effects of clearing heat and removing toxicity, promoting blood circulation to remove blood stasis, tonifying middle-jiao and Qi, healing sore and promoting tissue regeneration, regulating qi to alleviate pain, and enhancing the immune function of a body, is used for treating myocarditis, is decocted by 100 plus 150ml of water for one dose per day and divided into two parts, and is taken in the morning and evening respectively, has a remarkable effect of treating myocarditis, treats both symptoms and root causes, is quick in effect, good in effect after healing, safe, reliable, free of obvious toxic and side effects, does not hurt the spleen and stomach, and is convenient for a patient to take for a long time.
The traditional Chinese medicine composition has the advantages of small number of medicines, easily obtained raw materials, simple process, low cost and high efficiency, and is beneficial to pharmaceutical enterprises to carry out medicine production and quality control; the product has low price and is easy to be accepted by patients.
The treatment cost of the invention is relatively low and is far lower than that of western medicine.
The invention also provides an oral preparation prepared from the traditional Chinese medicine composition for treating myocarditis, which comprises oral liquid, tablets, capsules, pills and the like, wherein the preferable dosage forms are tablets and capsules, and one dose is taken every day in the morning and at night.
The traditional Chinese medicine composition can be prepared into various dosage forms. For example, the decocted liquid medicine is sterilized and disinfected and then packaged to prepare oral liquid; or concentrating the decoction, oven drying, adding pharmaceutically acceptable adjuvants, and making into tablet, capsule, pill, etc.
The medically acceptable auxiliary materials comprise starch, dextrin, sodium carboxymethylcellulose, polyethylene glycol, calcium hydrophosphate, sodium alginate, potassium sorbate and the like.
The above description is only for the purpose of illustrating the preferred embodiments of the present invention and is not to be construed as limiting the present invention in any way, and it will be apparent to those skilled in the art that the above description of the present invention can be applied to various modifications, equivalent variations or modifications without departing from the spirit and scope of the present invention.

Claims (4)

1. A traditional Chinese medicine composition for treating myocarditis is characterized by comprising the following components in parts by weight: 3-9 parts of evergreen; 6-12 parts of dogbane leaves; 9-18 parts of achyranthes aspera and abelmoschus manihot; 15-30 parts of mistletoe.
2. The traditional Chinese medicine for treating myocarditis according to claim 1, which is characterized by comprising the following raw material medicines in parts by weight: 9 parts of evergreen; 12 parts of dogbane leaves; 18 parts of achyranthes aspera and abelmoschus manihot; 15-30 parts of mistletoe.
3. An oral preparation for treating myocarditis, which is prepared from the traditional Chinese medicine composition of any one of claims 1 or 2.
4. An oral formulation for the treatment of myocarditis according to claim 3, comprising an oral liquid, tablet, capsule, pill, preferably capsule and tablet.
CN202110561632.5A 2020-05-28 2021-05-23 Traditional Chinese medicine composition for treating myocarditis Withdrawn CN113144076A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN202010464487.4A CN111419970A (en) 2020-05-28 2020-05-28 Traditional Chinese medicine composition for treating myocarditis
CN2020104644874 2020-05-28

Publications (1)

Publication Number Publication Date
CN113144076A true CN113144076A (en) 2021-07-23

Family

ID=71553169

Family Applications (2)

Application Number Title Priority Date Filing Date
CN202010464487.4A Pending CN111419970A (en) 2020-05-28 2020-05-28 Traditional Chinese medicine composition for treating myocarditis
CN202110561632.5A Withdrawn CN113144076A (en) 2020-05-28 2021-05-23 Traditional Chinese medicine composition for treating myocarditis

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CN202010464487.4A Pending CN111419970A (en) 2020-05-28 2020-05-28 Traditional Chinese medicine composition for treating myocarditis

Country Status (1)

Country Link
CN (2) CN111419970A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111419970A (en) * 2020-05-28 2020-07-17 仲崇允 Traditional Chinese medicine composition for treating myocarditis

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111419970A (en) * 2020-05-28 2020-07-17 仲崇允 Traditional Chinese medicine composition for treating myocarditis

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111419970A (en) * 2020-05-28 2020-07-17 仲崇允 Traditional Chinese medicine composition for treating myocarditis

Also Published As

Publication number Publication date
CN111419970A (en) 2020-07-17

Similar Documents

Publication Publication Date Title
CN102920806B (en) Nerve-soothing blood-pressure-reducing traditional Chinese medicine tea
CN108524673A (en) A kind of Chinese medicine composition and its application
CN113144076A (en) Traditional Chinese medicine composition for treating myocarditis
CN102805807B (en) Traditional Chinese medical composition for treating coronary heart disease and preparation method and applications thereof
CN113181258A (en) A Chinese medicinal composition for treating menoxenia, dysmenorrhea, and amenorrhea
CN102973841A (en) Traditional Chinese medicine used for treating arthromeningitis
CN103520652B (en) Traditional Chinese medicine composition for treating liver cancer
CN102988747B (en) Aristida triseta electuary for reducing hypertension, hyperglycemia and hyperlipidemia and preparation method thereof
CN106581585A (en) Medicine composition for treating gastric ulcer
CN113171414A (en) A Chinese medicinal composition for treating coronary heart disease and angina pectoris
CN101152223A (en) Use of poplar leaf phenols extract in treating cardiovascular disease and extracting method thereof
CN105193993B (en) A kind of Chinese medicine composition with blood fat reducing function and preparation method thereof and purposes
CN106620253B (en) Traditional Chinese medicine composition for treating bradyarrhythmia
CN104524461A (en) Medicine composition for treating myocarditis and application thereof
CN111514236A (en) Traditional Chinese medicine composition for treating myocardial infarction (infarction)
CN111714601A (en) A Chinese medicinal composition for treating fungal infection
CN111759960A (en) Traditional Chinese medicine composition for miscarriage prevention
CN105125985A (en) Chinese and western medicine compound preparation for treating senile chronic bronchitis and preparation method thereof
CN111544470A (en) Traditional Chinese medicine composition for treating heart failure
CN111759908A (en) Traditional Chinese medicine composition for treating urticaria
CN113599423A (en) Traditional Chinese medicine composition for treating anemia
CN111759936A (en) A Chinese medicinal composition for treating dermatoses
CN113648392A (en) Traditional Chinese medicine composition for treating cerebral infarction
CN116077568A (en) Traditional Chinese medicine composition for treating abdominal mass
CN116077589A (en) Traditional Chinese medicine composition for treating senile dementia

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication
WW01 Invention patent application withdrawn after publication

Application publication date: 20210723